Biannual report reveals global malware data and trends collected from the first half of the year SCHAFFHAUSEN, Switzerland, July 30, 2024 (Korea Bizwire) – Acronis, a global leader in cybersecurity and data protection, today shared new research findings from the first half of 2024 in its biannual cyberthreats report by the Acronis Threat Research Unit. Titled, “Acronis Cyberthreats Report H1 [...]
The CHMP positive opinion is based on the EFFISAYIL® 2 trial, which showed that no flares were observed after week 4 of SPEVIGO® administered subcutaneously. During the 48-week trial, an 84% reduction of the risk of GPP flares was observed. GPP is a rare, chronic, heterogenous neutrophilic inflammatory disease associated with skin flares and systemic [...]
VANCOUVER, British Columbia, July 29, 2024 (Korea Bizwire) – Bedford Metals Corp. (TSX-V: BFM, FWB: O8D, ISIN: CA0762301012) (the “Company” or “Bedford”) is pleased to announce that it has received the necessary exploration permit from the Ministry of Environment for its 2024 prospecting program at the Ubiquity Lake Uranium Project in Northern Saskatchewan. This permit marks a [...]
SHANGHAI, July 26, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and its wholly-owned subsidiary TopAlliance Biosciences Inc. (TopAlliance Biosciences), announce that the Committee for Medicinal Products for Human Use (CHMP) of the [...]
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseases Launch across Europe, starting today, strengthens well-established Sandoz immunology portfolio in Europe, leveraging existing footprint Pyzchiva® first ustekinumab biosimilar to launch in Europe with all reference medicine strengths, including 130mg vial initiation [...]
VANCOUVER, British Columbia, July 23, 2024 (Korea Bizwire) – Bedford Metals Corp. (TSX-V: BFM, FWB: O8D, ISIN: CA0762301012) (the “Company” or “Bedford”) is pleased to announce its 2024 Phase I field program for the Close Lake Uranium Project, located on the west side of the Athabasca Basin. Results from this program will be integrated with historical datasets [...]
VANCOUVER, British Columbia, July 22, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that the United States Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for ZW191, [...]
BOSTON , July 19, 2024 (Korea Bizwire) – The Extreme Event Solutions group at Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, estimates industry insured losses to onshore property from wind in the U.S. for Hurricane Beryl will range between USD 2 billion to USD 3 billion. Meteorological History of Beryl Beryl [...]
The circular economy, a critical strategy for delivering a lower-emission, more sustainable future by reusing materials and minimising waste has made disappointingly little impact on the global plastics industry in the last decade as it struggled to navigate traditional value chains and business practices according to a new report by Wood Mackenzie. The July Horizons [...]
Milestones reached in cardiovascular, renal, metabolic health (CRM), and oncology Further data read-outs expected in 2024 in oncology, mental health, and pulmonary fibrosis Strong first half net sales growth of 7.4%* year on year Boehringer Ingelheim, a leading research-driven biopharmaceutical company, reported on Thursday significant progress in its pipeline across key therapeutic areas as it [...]